Published in N Engl J Med on April 04, 2011
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (2013) 3.15
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ (2014) 2.62
Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the Surgical Treatment for Ischemic Heart Failure trial. J Thorac Cardiovasc Surg (2014) 2.62
Prevalence of regional myocardial thinning and relationship with myocardial scarring in patients with coronary artery disease. JAMA (2013) 2.29
Severity of Remodeling, Myocardial Viability, and Survival in Ischemic LV Dysfunction After Surgical Revascularization. JACC Cardiovasc Imaging (2015) 2.10
Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail (2012) 1.92
Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected]. J Am Coll Cardiol (2014) 1.74
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation. N Engl J Med (2016) 1.59
Importance of Angina in Patients With Coronary Disease, Heart Failure, and Left Ventricular Systolic Dysfunction: Insights From STICH. J Am Coll Cardiol (2015) 1.55
Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure). JACC Heart Fail (2014) 1.41
[Summary of the article: Bonow RO, Maurer G, Lee KL et al. Myocardial viability and survival in ischaemic left ventricular dysfunction. NEJM, 2011; doi:10.1056/NEJMoa1100358]. Kardiol Pol (2011) 1.39
Clinical implications of cardiac hyperpolarized magnetic resonance imaging. J Cardiovasc Magn Reson (2013) 1.07
Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction. Circulation (2011) 0.96
Underestimating medical therapy for coronary disease... again. N Engl J Med (2011) 0.95
Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Myocardial imaging should not exclude patients with ischemic heart failure from coronary revascularization. Circ Cardiovasc Imaging (2012) 0.90
Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol (2012) 0.89
The role of cardiac magnetic resonance imaging following acute myocardial infarction. Eur Radiol (2012) 0.89
Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI. Cardiovasc Diagn Ther (2012) 0.88
Hotline update of clinical trials and registries presented at the American College of Cardiology Congress 2011. Clin Res Cardiol (2011) 0.85
Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease. J Am Coll Cardiol (2016) 0.83
Simultaneous assessment of cardiac metabolism and perfusion using copolarized [1-(13) C]pyruvate and (13) C-urea. Magn Reson Med (2016) 0.82
Surgical approaches to left ventricular reconstruction: a matter of perspective. Heart Fail Rev (2013) 0.82
The potential value of integrated natriuretic peptide and echo-guided heart failure management. Cardiovasc Ultrasound (2014) 0.82
Chronic total occlusion: To treat or not to treat. World J Cardiol (2014) 0.82
Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. J Cardiovasc Magn Reson (2011) 0.81
Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2011) 0.80
Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) IMAGE HF Project I-A: study protocol for a randomized controlled trial. Trials (2013) 0.80
The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction. Int J Cardiovasc Imaging (2013) 0.79
Myocardial viability: what we knew and what is new. Cardiol Res Pract (2012) 0.79
Imaging: myocardial thinning is not always transmural scarring. Nat Rev Cardiol (2013) 0.78
The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results. JACC Heart Fail (2013) 0.78
The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET. Eur J Nucl Med Mol Imaging (2013) 0.78
Head-to-head comparison of contrast-enhanced cardiovascular magnetic resonance and ²⁰¹Thallium single photon emission computed tomography for prediction of reversible left ventricular dysfunction in chronic ischaemic heart disease. Int J Cardiovasc Imaging (2011) 0.78
Revascularization in Severe Left Ventricular Dysfunction: Does Myocardial Viability Even Matter? Clin Med Insights Cardiol (2015) 0.78
Temporary epicardial cardiac resynchronisation versus conventional right ventricular pacing after cardiac surgery: study protocol for a randomised control trial. Trials (2012) 0.78
Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol (2015) 0.78
Myocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass grafting. PLoS One (2013) 0.77
Cardiac MR for the assessment of myocardial viability. Methodist Debakey Cardiovasc J (2013) 0.77
Cardiovascular imaging in clinical practice: what does late gadolinium enhance? JAMA (2013) 0.77
Stable angina pectoris: antianginal therapies and future directions. Nat Rev Cardiol (2011) 0.77
Impaired coronary flow reserve is the most important marker of viable myocardium in the myocardial segment-based analysis of dual-isotope gated myocardial perfusion single-photon emission computed tomography. Korean J Radiol (2014) 0.77
PET imaging in heart failure: the role of new tracers. Heart Fail Rev (2017) 0.77
The role of myocardial viability in contemporary cardiac practice. Heart Fail Rev (2017) 0.77
Cardiac ⁹⁹mTc sestamibi SPECT and ¹⁸F FDG PET as viability markers in Takotsubo cardiomyopathy. Int J Cardiovasc Imaging (2014) 0.76
Outcome Reporting in Cardiac Surgery Trials: Systematic Review and Critical Appraisal. J Am Heart Assoc (2015) 0.76
Myocardial viability in ischemic left ventricular dysfunction. N Engl J Med (2011) 0.76
Review of Journal of Cardiovascular Magnetic Resonance 2011. J Cardiovasc Magn Reson (2012) 0.76
Low-carbohydrate diet versus euglycemic hyperinsulinemic clamp for the assessment of myocardial viability with 18F-fluorodeoxyglucose-PET: a pilot study. Int J Cardiovasc Imaging (2013) 0.76
MRI monitoring of function, perfusion and viability in microembolized moderately ischemic myocardium. Int J Cardiovasc Imaging (2015) 0.75
Chronic total occlusion: no more meta-analysis, please-a randomized clinical trial is urgently needed. J Thorac Dis (2015) 0.75
Bilateral vs unilateral internal mammary revascularization in patients with left ventricular dysfunction. World J Cardiol (2017) 0.75
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy. Tex Heart Inst J (2016) 0.75
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy. Curr Cardiol Rep (2016) 0.75
Myocardial viability in ischemic left ventricular dysfunction. N Engl J Med (2011) 0.75
Gene Therapy in Cardiac Surgery: Clinical Trials, Challenges, and Perspectives. Ann Thorac Surg (2016) 0.75
The feasibility of myocardial infarct visualization using atrial kick induced strain (AKIS) contrast. Ultrasound Med Biol (2014) 0.75
Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques. World J Cardiol (2017) 0.75
Role of PET-CT in the assessment of myocardial viability in patients with left ventricular dysfunction. Indian Heart J (2016) 0.75
Ventricular Dysfunction in Patients with Acute Coronary Syndrome Undergoing Coronary Surgical Revascularization: Prognostic Impact on Long-Term Outcomes. PLoS One (2016) 0.75
Depressed Exercise Peak Ejection Rate Detected on Ambulatory Radionuclide Monitoring Reflects End-Stage Cardiac Inotropic Reserve and Predicts Mortality in Ischaemic Cardiomyopathy. Cardiol Res (2012) 0.75
Prognostic power of global 2D strain according to left ventricular ejection fraction in patients with ST elevation myocardial infarction. PLoS One (2017) 0.75
Myocardial viability in ischemic left ventricular dysfunction. N Engl J Med (2011) 0.75
Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2014) 0.75
Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Mater Sociomed (2011) 0.75
Reduced Right Ventricular Function Predicts Long-Term Cardiac Re-Hospitalization after Cardiac Surgery. PLoS One (2015) 0.75
Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventions. BMC Cardiovasc Disord (2015) 0.75
Role of cardiovascular magnetic resonance in assessment of acute coronary syndrome. World J Cardiol (2014) 0.75
Interventional therapies in ischemic ventricular dysfunction: facts and versions! Ann Transl Med (2016) 0.75
Mid-term results of coronary bypass graft surgery in patients with ischaemic left ventricular systolic dysfunction and no detected myocardial viability. Interact Cardiovasc Thorac Surg (2016) 0.75
A Novel Approach for Identifying Ischemic Cardiomyopathy. Korean Circ J (2016) 0.75
The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure. Card Fail Rev (2016) 0.75
The Potential of Clinical Phenotyping of Heart Failure With Imaging Biomarkers for Guiding Therapies: A Focused Update. JACC Cardiovasc Imaging (2017) 0.75
Microvascular function, is there a link to myocardial viability: Is this another piece to the puzzle? J Nucl Cardiol (2016) 0.75
Rethinking Revascularization in Left Ventricular Systolic Dysfunction. Circ Heart Fail (2017) 0.75
Hibernating substrate of ventricular tachycardia: a three-dimensional metabolic and electro-anatomic assessment. J Interv Card Electrophysiol (2017) 0.75
Intra-procedural determination of viability by myocardial deformation imaging: a randomized prospective study in the cardiac catheter laboratory. Clin Res Cardiol (2017) 0.75
Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis. BMC Cardiovasc Disord (2017) 0.75
Lipids, statins, and clinical outcomes in heart failure: rethinking the data. Heart Fail Rev (2014) 0.75
Surgical ventricular restoration: where do we go from here? Heart Fail Rev (2015) 0.75
SPECT and PET in ischemic heart failure. Heart Fail Rev (2017) 0.75
Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol (2002) 4.11
A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol (2002) 3.97
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg (2007) 3.45
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet (2003) 2.64
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol (2007) 2.50
STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. J Am Coll Cardiol (2010) 2.39
Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation (2004) 2.20
Navigating the crossroads of coronary artery disease and heart failure. Circulation (2006) 2.06
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation (2003) 1.99
Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium. Circulation (1993) 1.90
Stunning, hibernation, and assessment of myocardial viability. Circulation (2008) 1.83
Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation (1997) 1.55
Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med (1997) 1.54
The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction. Eur Heart J (2001) 1.54
Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol (1998) 1.45
Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol (1993) 1.43
Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol (1994) 1.40
Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol (2007) 1.36
Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging (2009) 1.30
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol (1999) 1.19
Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation (1999) 1.14
Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (1999) 1.13
Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol (1996) 1.11
Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (2004) 1.06
Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol (2002) 1.06
Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am Heart J (2003) 1.03
Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol (1998) 0.98
Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol (1995) 0.98
Effect of revascularization on long-term survival in patients with ischemic left ventricular dysfunction and a wide range of viability. Am J Cardiol (2010) 0.96
Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med (1998) 0.95
Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol (1996) 0.94
Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (2000) 0.93
Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization. Am J Cardiol (2004) 0.90
Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol (2003) 0.90
Prognosis of hibernating myocardium is independent of recovery of function: evidence from a routine based follow-up study. Nucl Med Commun (2002) 0.89
Prognostic value of myocardial viability determined by a 201Tl SPECT study in patients with previous myocardial infarction and mild-to-moderate myocardial dysfunction. Nucl Med Commun (2003) 0.88
The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol (2010) 0.87
Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability. Eur J Heart Fail (2003) 0.87
Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr (2005) 46.32
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med (2004) 18.38
Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr (2009) 14.63
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Recommendations for chamber quantification. Eur J Echocardiogr (2006) 11.39
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr (2009) 7.69
Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med (2014) 7.23
Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96
Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med (2008) 6.77
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med (2005) 6.53
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves. N Engl J Med (2015) 6.28
Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med (2005) 6.27
Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med (2013) 6.21
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol (2007) 5.91
Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*. Crit Care Med (2013) 5.88
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA (2013) 5.31
Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13
Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med (2015) 4.77
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr (2009) 4.69
SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr (2009) 4.66
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med (2012) 4.49
Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol (2007) 4.49
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med (2015) 4.39
Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med (2008) 4.33
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA (2006) 4.30
Music, imagery, touch, and prayer as adjuncts to interventional cardiac care: the Monitoring and Actualisation of Noetic Trainings (MANTRA) II randomised study. Lancet (2005) 4.29
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation (2003) 3.97
Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology (2003) 3.70
The CT-STAT (Coronary Computed Tomographic Angiography for Systematic Triage of Acute Chest Pain Patients to Treatment) trial. J Am Coll Cardiol (2011) 3.58
Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation (2003) 3.57
Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. JAMA (2013) 3.48
The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg (2007) 3.45
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis. Circulation (2003) 3.45
Cardiovascular effects of sildenafil during exercise in men with known or probable coronary artery disease: a randomized crossover trial. JAMA (2002) 3.44
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med (2002) 3.35
Blood transfusion and infection after cardiac surgery. Ann Thorac Surg (2013) 3.35
Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): design and rationale. Am Heart J (2007) 3.34
American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr (2011) 3.32
Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol (2013) 3.15
Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J (2006) 3.14
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation (2013) 3.14
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation. N Engl J Med (2015) 3.11
Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation (2006) 3.08
Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. Ann Intern Med (2013) 3.08
Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation (2003) 3.08
Off-pump versus on-pump coronary artery bypass graft surgery: differences in short-term outcomes and in long-term mortality and need for subsequent revascularization. Circulation (2007) 3.05
Left ventricular function and exercise capacity. JAMA (2009) 2.99
Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr (2008) 2.99
Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation (2002) 2.97
Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol (2004) 2.95